It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

vaccinations

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Why Japan is largely a spectator in the coronavirus vaccine race

Business Dec 11, 2020

Why Japan is largely a spectator in the coronavirus vaccine race

by Osamu Tsukimori

A total of 52 vaccine candidates were in clinical evaluation worldwide as of Tuesday, of which only one was Japanese.

U.S. nears final COVID-19 vaccine review as daily deaths top 3,250

World Dec 10, 2020

U.S. nears final COVID-19 vaccine review as daily deaths top 3,250

Steady movement toward a vaccine rollout on the eve of a critical review by leading U.S. medical experts comes as COVID-19 caseloads surged alarmingly higher, straining health care systems.

U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions

World / Science & Health Dec 10, 2020

U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions

Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history.

China’s state-backed coronavirus vaccine has 86% efficacy, says UAE

World / Science & Health Dec 9, 2020

China’s state-backed coronavirus vaccine has 86% efficacy, says UAE

China’s state-backed coronavirus vaccine protected 86% of people from getting COVID-19 in trials conducted in the United Arab Emirates, reported media outlets including Reuters, citing the UAE’s health ministry. The vaccine, developed by Sinopharm unit China National Biotec Group Co., has been granted emergency use ...

Testing times: More work needed on AstraZeneca/Oxford vaccine trials

World / Science & Health Dec 9, 2020

Testing times: More work needed on AstraZeneca/Oxford vaccine trials

by Kate Kelland

A Lancet study gave few extra clues about why efficacy was 62% for trial participants given two full doses, but 90% for a smaller subgroup given a half, then a full dose.

Why the U.K. approved a COVID-19 vaccine first

World / Science & Health Dec 3, 2020

Why the U.K. approved a COVID-19 vaccine first

by Benjamin Mueller

Doses of the Pfizer-BioNTech vaccine will be injected starting next week, the government said.

U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine

World / Science & Health Nov 29, 2020

U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine

The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus. Clearance is possible as soon as early next week, according to a person familiar ...

After admitting error, AstraZeneca faces hard questions on vaccine

World / Science & Health Nov 26, 2020

After admitting error, AstraZeneca faces hard questions on vaccine

by Rebecca Robbins and Benjamin Mueller

Scientists said a series of irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results.

Decades of work, and half a dose of fortune, drove Oxford vaccine success

World / Science & Health | FOCUS Nov 24, 2020

Decades of work, and half a dose of fortune, drove Oxford vaccine success

by Alistair Smout, Kate Kelland and Ludwig Burger

The Oxford vaccinologists were exhilarated on Monday when drugmaker AstraZeneca, with whom they developed the shot, announced that it could be around 90% effective.

U.S. plans first vaccinations in weeks, Operation Warp Speed chief says

World Nov 23, 2020

U.S. plans first vaccinations in weeks, Operation Warp Speed chief says

Vaccinations against COVID-19 in the U.S. will "hopefully” start in less than three weeks, according to the head of the federal government’s program to accelerate a vaccine. "On the 11th or on the 12th of December, hopefully the first people will be immunized across the ...

Two companies say their vaccines are 95% effective. What does that mean?

World / Science & Health Nov 21, 2020

Two companies say their vaccines are 95% effective. What does that mean?

by Carl Zimmer

You might assume that 95 out of every 100 people vaccinated will be protected from COVID-19. But that’s not how the math works.

Can first vaccines bring herd immunity? Experts have doubts.

World / Science & Health Nov 19, 2020

Can first vaccines bring herd immunity? Experts have doubts.

by Ludwig Burger and Kate Kelland

Figuring out what's needed to achieve herd immunity with COVID-19 vaccines involves a range of factors, several of which are unknown.

« 1 … 64 65 66 … 74 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times